Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes-Reference-Cited by-同舟云学术

Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes

Published:2013-05 Issue:2 Volume:98 Page:305-313
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Zhou Jiansong,Li Baohua,Peng Chanjuan,Wang Fenfen,Fu Zhiqin,Zhou Caiyun,Hong Die,Ye Feng,Lü Weiguo,Xie Xing

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference34 articles.

1. Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers;Chang;Cancer Gene Ther.,2010

2. Pioneering HIV treatment would use interference and gene therapy;Check;Nature,2005

3. Suppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA;Courtete;Mol. Cancer Ther.,2007

4. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells;DeFilippis;J. Virol.,2003

5. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation;Fehrmann;Oncogene,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Micro-Immunotherapy Medicine 2LPAPI® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells;Cancers;2024-04-05

2. Advances in application of CRISPR-Cas13a system;Frontiers in Cellular and Infection Microbiology;2024-02-19

3. Optimal delivery of RNA interference by viral vectors for cancer therapy;Molecular Therapy;2023-11

4. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis;Antiviral Research;2023-08

5. Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression;2023-03-15